Jay Sarup

2.0k total citations · 1 hit paper
15 papers, 1.7k citations indexed

About

Jay Sarup is a scholar working on Oncology, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Jay Sarup has authored 15 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 9 papers in Molecular Biology and 9 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Jay Sarup's work include HER2/EGFR in Cancer Research (10 papers), Monoclonal and Polyclonal Antibodies Research (9 papers) and Glycosylation and Glycoproteins Research (5 papers). Jay Sarup is often cited by papers focused on HER2/EGFR in Cancer Research (10 papers), Monoclonal and Polyclonal Antibodies Research (9 papers) and Glycosylation and Glycoproteins Research (5 papers). Jay Sarup collaborates with scholars based in United States, United Kingdom and Germany. Jay Sarup's co-authors include H. Michael Shepard, Christopher C. Benz, Ester B. Coronado, Randolph M. Johnson, C. Kent Osborne, Debasish Tripathy, Gary K. Scott, Dennis J. Slamon, Arnold Fridland and B M Fendly and has published in prestigious journals such as Science, Journal of Biological Chemistry and Biochemistry.

In The Last Decade

Jay Sarup

15 papers receiving 1.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Estrogen-dependent, tamoxifen-resistant tumorigenic growth of MCF-7 cells transfected with HER2/neu

1992 625 citations Christopher C. Benz, Gary K. Scott et al. Breast Cancer Research and Treatment profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jay Sarup United States	14	1.1k	815	690	324	202	15	1.7k
Amol Tandon United States	11	1.4k 1.2×	887 1.1×	700 1.0×	177 0.5×	506 2.5×	16	2.0k
Michael T. Lipari United States	21	525 0.5×	861 1.1×	483 0.7×	190 0.6×	176 0.9×	26	1.8k
Gabriele Schaefer United States	17	899 0.8×	900 1.1×	784 1.1×	76 0.2×	66 0.3×	31	1.7k
Kendall D. Carey United States	10	1.1k 0.9×	951 1.2×	651 0.9×	82 0.3×	121 0.6×	12	1.9k
Ronald N. Buick Canada	18	669 0.6×	751 0.9×	229 0.3×	154 0.5×	285 1.4×	25	1.5k
Wenle Xia United States	23	1.9k 1.7×	1.3k 1.6×	881 1.3×	126 0.4×	254 1.3×	31	2.8k
Keng‐Hsueh Lan Taiwan	13	1.5k 1.3×	1.5k 1.9×	760 1.1×	101 0.3×	325 1.6×	21	2.5k
Shang‐Fan Yu United States	22	833 0.7×	929 1.1×	864 1.3×	107 0.3×	85 0.4×	45	1.7k
Edward Rosfjord United States	19	1.0k 0.9×	938 1.2×	358 0.5×	128 0.4×	271 1.3×	39	1.9k
Stephen L. Eck United States	21	400 0.3×	591 0.7×	113 0.2×	498 1.5×	114 0.6×	35	1.3k

Countries citing papers authored by Jay Sarup

Since Specialization

Citations

This map shows the geographic impact of Jay Sarup's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jay Sarup with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jay Sarup more than expected).

Fields of papers citing papers by Jay Sarup

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jay Sarup. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jay Sarup. The network helps show where Jay Sarup may publish in the future.

Co-authorship network of co-authors of Jay Sarup

This figure shows the co-authorship network connecting the top 25 collaborators of Jay Sarup. A scholar is included among the top collaborators of Jay Sarup based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jay Sarup. Jay Sarup is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Sarup, Jay, Jin Pei, Xiaomei Bai, et al.. (2008). Human epidermal growth factor receptor (HER-1:HER-3) Fc-mediated heterodimer has broad antiproliferative activityin vitroand in human tumor xenografts. Molecular Cancer Therapeutics. 7(10). 3223–3236. 28 indexed citations

Faltynek, Connie R., Su Wang, Deborah Miller, et al.. (1995). Inhibition of T Lymphocyte Actnation by a Novel p56^lckTyrosine Kinase Inhibitor. Journal of enzyme inhibition. 9(2). 111–122. 19 indexed citations

Miller, Deborah, Su Wang, Marian Kelley, et al.. (1995). Approach to the discovery of novel, selective inhibitors of p56^lck tyrosine kinase: Identification of non‐hydroxylated chromones as p56^lck inhibitors. Drug Development Research. 34(4). 344–352. 18 indexed citations

Dolle, Roland E., Joseph A. Dunn, Mark A. Bobko, et al.. (1994). 5,7-Dimethoxy-3-(4-Pyridinyl)Quinoline Is a Potent and Selective Inhibitor of Human Vascular .beta.-Type Platelet-Derived Growth Factor Receptor Tyrosine Kinase. Journal of Medicinal Chemistry. 37(17). 2627–2629. 36 indexed citations

Benz, Christopher C., Gary K. Scott, Jay Sarup, et al.. (1992). Estrogen-dependent, tamoxifen-resistant tumorigenic growth of MCF-7 cells transfected with HER2/neu. Breast Cancer Research and Treatment. 24(2). 85–95. 625 indexed citations breakdown →

Scott, G K, R. M. Johnson, Jay Sarup, et al.. (1991). p185HER2 signal transduction in breast cancer cells. Journal of Biological Chemistry. 266(22). 14300–14305. 83 indexed citations

Sarup, Jay, R. M. Johnson, K. L. King, et al.. (1991). Characterization of an anti-p185HER2 monoclonal antibody that stimulates receptor function and inhibits tumor cell growth.. PubMed. 1(2). 72–82. 142 indexed citations

Shepard, H. Michael, Gail D. Lewis Phillips, Jay Sarup, et al.. (1991). Monoclonal antibody therapy of human cancer: Taking the HER2 protooncogene to the clinic. Journal of Clinical Immunology. 11(3). 117–127. 254 indexed citations

Fendly, B M, Claire E. Kotts, Doris Vetterlein, et al.. (1990). The extracellular domain of HER2/neu is a potential immunogen for active specific immunotherapy of breast cancer.. PubMed. 9(5). 449–55. 39 indexed citations

10.

Lupu, Ruth, Rámón Colomer, Gerhard Zugmaier, et al.. (1990). Direct Interaction of a Ligand for the erb B2 Oncogene Product with the EGF Receptor and p185 ^{erb B2}. Science. 249(4976). 1552–1555. 252 indexed citations

11.

Sarup, Jay, et al.. (1989). Regulation of purine deoxynucleoside phosphorylation by deoxycytidine kinase from human leukemic blast cells. Biochemical Pharmacology. 38(16). 2601–2607. 17 indexed citations

12.

Sarup, Jay, Kanury V. S. Rao, Richard Williams, & Colin Fox. (1988). Resolution of high and low affinity progesterone receptors from human breast carcinoma T47D cells.. Journal of Biological Chemistry. 263(12). 5624–5633. 12 indexed citations

13.

Sarup, Jay, et al.. (1988). Decreased progesterone binding and attenuated progesterone action in cultured human breast carcinoma cells treated with epidermal growth factor.. PubMed. 48(18). 5071–8. 43 indexed citations

14.

Sarup, Jay & Arnold Fridland. (1987). Identification of purine deoxyribonucleoside kinases from human leukemia cells: substrate activation by purine and pyrimidine deoxyribonucleosides. Biochemistry. 26(2). 590–597. 51 indexed citations

15.

Sarup, Jay, et al.. (1981). Identification of the mechanism of activation of 9-beta-D-arabinofuranosyladenine in human lymphoid cells using mutants deficient in nucleoside kinases.. PubMed. 41(11 Pt 1). 4478–83. 66 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact